Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Asian Stocks Up as Possible Brexit Deal Brings Christmas Cheer

Published 12/23/2020, 10:02 PM
Updated 12/23/2020, 10:07 PM
© Reuters.

© Reuters.

By Gina Lee

Investing.com – Asia Pacific stocks were mostly up on Thursday morning, with the prospect of a Brexit deal giving markets a pre-Christmas boost.

Japan’s Nikkei 225 gained 0.53% by 9:52 PM ET (2:52 AM GMT).

South Korea’s KOSPI rose 0.86%. The country has signed deals with Pfizer Inc (NYSE:PFE) and Johnson & Johnson's (NYSE:JNJ) Janssen to import COVID-19 vaccines to cover up to 16 million people as it continues to deal with a third wave of COVID-19 cases, Prime Minister Chung Sye Kyun said on Thursday.

In Australia, the ASX 200 gained 0.43%

Hong Kong’s Hang Seng Index was up 0.22%. The new B.1.1.7 strain of the COVID-19 virus could already be in the city, with two students returning from the U.K. suspected to be infected with the strain. U.K. Prime Minister Boris Johnson has imposed tougher restrictions across England as the B.1.1.7 strain continues to spread across the country.

China’s Shanghai Composite edged down 0.17% while the Shenzhen Component inched up 0.08%. The State Administration for Market Regulation said on Thursday that it will launch an investigation into Alibaba (NYSE:BABA) Group Holding Ltd (HK:9988) for suspected monopolistic behaviour and will summon the company’s Ant Group to meet in the coming days.

Although a formal announcement of the Brexit deal between the U.K. and the European Union has yet to be released, hopes that an economic rupture on Jan. 1 could be avoided gave shares a boost.

“The framework for a Brexit trade deal gave investors the green light to start buying everything in Europe,” OANDA senior market analyst Edward Moya told Reuters.

The news from Europe helped overshadow threats from U.S. President Donald Trump that he would not sign off on the COVID-19 relief bill passed by Congress earlier in the week. Although House of Representatives Speaker Nancy Pelosi was quick to echo Trump’s call for larger individual stimulus checks than offered in the bill, whether the House of Representatives would succeed in passing this additional measure during a pro forma session later in the day remains to be seen.

However, Trump’s comments that the bill was “a disgrace” that he might not sign did not seem to have much impact in the market.

On the data front, jobless claims for the past week fell to 803,000 from the previous week’s 892,000 claims and the 885,000 claims in forecasts prepared by Investing.com. However, core durable goods orders grew 0.4% month-on-month in November, down from the 0.5% growth in forecasts and the 1.9% growth seen in October amid ever-increasing numbers of COVID-19 cases.

“Risk-on sentiment is guiding markets so far today and it appears to be weighted more toward possible optimism toward a Brexit deal and the cherry-picked parts of U.S. releases, rather than Trump’s reckless antics over signing the stimulus and funding bill,” Scotiabank head of capital markets economics Derek Holt told Reuters.

Other investors were more cautious, with a little over a week remaining until 2021.

“Right now we have a lot of animal spirits surging into year-end … as constructive as I am on markets in the broader term, I do expect there will be a hangover of sorts to process this over-extension sometime later this winter,” Tallbacken Capital Advisors founder and CEO Michael Purves told Bloomberg.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.